Bausch Health Companies Inc.

BHC

CA0717341071

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 13:57:49 2025-07-14 EDT			5-day change	1st Jan Change
6.305 ^USD	-1.79%		-8.30%	-21.84%

07-10	Bausch Health Names Steven Lee Chief Accounting Officer	MT
07-10	Bausch Health Appoints New Chief Accounting Officer	MT

Bausch Health Companies Insider Bought Shares Worth $14,700,257, According to a Recent SEC Filing

Published on 2025-06-13 at 03:17

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Bausch Health Companies Inc.

Bausch Health Names Steven Lee Chief Accounting Officer	07-10	MT
Bausch Health Appoints New Chief Accounting Officer	07-10	MT
Bausch Health Companies Inc. Appoints Steven Lee as Chief Accounting Officer, Senior Vice President and Controller, Effective July 14, 2025	07-10	CI
Bausch Health Says its Acne Treatment is Now Available Through Ontario and Nova Scotia Public Drug Plans	07-09	MT
TSX rises as investors assess US-Canada trade talks	06-30	RE
TSX hits record high as investors assess economic data	06-27	RE
Bausch + Lomb Brief: Includes Upsized US$2.325 Billion Term Loan Facility	06-26	MT
Bausch + Lomb Brief: Closes Upsized 675 Million Euro Senior Secured Notes Offering and Partial Credit Agreement Refinancing	06-26	MT
TSX dips on Middle East conflict concerns	06-19	RE
Bausch + Lomb Prices Upsizes and Prices a 675-Million Euro Senior Secured Notes Offering	06-18	MT
Bausch + Lomb Brief: Prices Upsized Senior Secured Notes Offering	06-18	MT
Toronto Stocks Up; Keyera Shares Up Following Deal for Plains' Natural Gas Liquids Assets	06-18	DJ
TSX rises with Fed decision on watch	06-18	RE
Bausch Health Companies Insider Bought Shares Worth $21,170,510, According to a Recent SEC Filing	06-17	MT
Bausch Health Companies Insider Bought Shares Worth $14,700,257, According to a Recent SEC Filing	06-13	MT
Bausch + Lomb Launching Senior Secured Notes Offering and Refinancing Credit Agreement	06-10	MT
Bausch + Lomb Brief: Launching Senior Secured Notes Offering and Refinancing Credit Agreement	06-10	MT
Bausch + Lomb Launches New Lubricating Eye Drops in the U.S.	06-04	MT
Bausch + Lomb Launches New Eye Drops in the U.S.	05-21	MT
Bausch Health Companies Inc - Enters Agreements With Icahn, Paulson, Kavanagh Groups - SEC Filing	05-21	RE
Bausch Health and Bausch + Lomb Brief: Cos Have Cited Amendment to Definitive Proxy Statement Relating to 2025 Annual Meeting of Shareholders On May 21, 2025	05-21	MT
Bausch Health Companies Inc. Announces Executive Changes, Effective June 2, 2025	05-15	CI
Bausch + Lomb Brief: Announcing the U.S. Launch of Zenlens CHROMA HOA scleral contact lenses	05-14	MT
Bausch + Lomb Says Received European CE Mark Approval for Preloaded LuxLife Full Range of Vision Intraocular Lens	05-07	MT
Bausch + Lomb Brief: Says Received European CE Mark Approval for Preloaded LuxLife Full Range of Vision Intraocular Lens	05-07	MT

Chart Bausch Health Companies Inc.

Duration

Period

BHC: Dynamic Chart

Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (GI), hepatology, neurology and dermatology, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the United States and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products, and other products. Its Solta Medical segment consists of global sales of Solta Medical aesthetic medical devices. Its Diversified segment consists of sales in the United States of pharmaceutical products in the areas of neurology and certain other therapeutic classes. Its Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, surgical and pharmaceutical products.

Employees

20,700

Sector

Pharmaceuticals

Calendar

07-29 - Q2 2025 Earnings Release

More about the company